Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

NCT02462603 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Edison Pharmaceuticals Inc